Understanding how childhood medulloblastoma begins to identify new treatments
Dr Sarah Badodi at Queen Mary University of London will use new models to discover how and why medulloblastoma develops, identifying new ways to target the cancer.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Dr Sarah Badodi at Queen Mary University of London will use new models to discover how and why medulloblastoma develops, identifying new ways to target the cancer.
Professor Sophie Postel-Vinay and Dr Lucia Cottone at University College London will look at whether osteosarcoma cells need a molecule called M1 to survive damage to their DNA.
Dr Thomas Oliver at University College London will investigate whether the genetic changes caused by radiotherapy could make diffuse midline glioma tumours less responsive to other treatments.
Dr Rebecca Hill and her team hope to develop new tools to test chemotherapy options that will combine with radiotherapy to treat high-risk medulloblastoma.
Professor Darren Hargrave aims to study electrical signals in the brain which could help diffuse midline glioma spread.
Professor Alex Thompson and his team at the University of Nottingham aim to learn more about leukaemia to support the development of kinder treatments.
Dr Maria Teresa Esposito hopes to learn more about a gene called SET in leukaemia and will test the best medicines to fight it.
Professor Suzanne Turner will investigate the behaviour of individual lymphoma cells in order to find out why treatments fail.
Dr Olivier Pardo will investigate how osteosarcoma cells which escape into the bloodstream survive to spread elsewhere in the body.